0 Evaluaciones

ID

12877

Descripción

EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol; ODM derived from: https://clinicaltrials.gov/show/NCT01119261

Link

https://clinicaltrials.gov/show/NCT01119261

Palabras clave

  1. 4/1/16 4/1/16 -
Subido en

4 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility Venous Thromboembolism NCT01119261

    Eligibility Venous Thromboembolism NCT01119261

    Inclusion Criteria
    Descripción

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
    Descripción

    venous thromboembolism; atrial fibrillation; coumarin

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1861172
    UMLS CUI [2]
    C0004238
    UMLS CUI [3]
    C0010206
    age ≥ 18 years
    Descripción

    age

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    ability to attend scheduled visits
    Descripción

    compliance behavior

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1321605
    signed informed consent
    Descripción

    informed consent

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Descripción

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    presence of a mechanical heart valve
    Descripción

    mechanical heart valve

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0493527
    severe cognitive impairment
    Descripción

    cognitive impairment

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1839000
    known genotype cyp2c9 or vkorc1 at start of the study
    Descripción

    genotype CYP2 gene VKOR gene

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0017431
    UMLS CUI [1,2]
    C1332829
    UMLS CUI [1,3]
    C1428184
    previous or current treatment with any coumarin
    Descripción

    therapy coumarin

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111
    UMLS CUI [1,2]
    C0010206
    pregnancy or lactation
    Descripción

    pregnancy; lactating

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    non-eligible subject
    Descripción

    Study Subject Participation Status

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C2348568

    Similar models

    Eligibility Venous Thromboembolism NCT01119261

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    C1512693 (UMLS CUI)
    venous thromboembolism; atrial fibrillation; coumarin
    Item
    patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
    boolean
    C1861172 (UMLS CUI [1])
    C0004238 (UMLS CUI [2])
    C0010206 (UMLS CUI [3])
    age
    Item
    age ≥ 18 years
    boolean
    C0001779 (UMLS CUI [1])
    compliance behavior
    Item
    ability to attend scheduled visits
    boolean
    C1321605 (UMLS CUI [1])
    informed consent
    Item
    signed informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    mechanical heart valve
    Item
    presence of a mechanical heart valve
    boolean
    C0493527 (UMLS CUI [1])
    cognitive impairment
    Item
    severe cognitive impairment
    boolean
    C1839000 (UMLS CUI [1])
    genotype CYP2 gene VKOR gene
    Item
    known genotype cyp2c9 or vkorc1 at start of the study
    boolean
    C0017431 (UMLS CUI [1,1])
    C1332829 (UMLS CUI [1,2])
    C1428184 (UMLS CUI [1,3])
    therapy coumarin
    Item
    previous or current treatment with any coumarin
    boolean
    C0087111 (UMLS CUI [1,1])
    C0010206 (UMLS CUI [1,2])
    pregnancy; lactating
    Item
    pregnancy or lactation
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Study Subject Participation Status
    Item
    non-eligible subject
    boolean
    C2348568 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial